SCHEMBL14420103

SCHEMBL14420103

CCCCc1cccc(CC(=O)OC)c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.43
ALOX5 P09917 1/20 0.41
PTGS2 P35354 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
BID P55957 3/20 0.39
MCL1 Q07820 3/20 0.39
BCL2L1 Q07817 2/20 0.39
BAK1 Q16611 2/20 0.39
KAT8 Q9H7Z6 2/20 0.39
PPARG P37231 2/20 0.39
EP300 Q09472 1/20 0.39
KAT2A Q92830 1/20 0.39
KAT2B Q92831 1/20 0.39
KAT5 Q92993 1/20 0.39
SAE1 Q9UBE0 1/20 0.39
PPARD Q03181 1/20 0.39
ICMT O60725 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26240068 0.84 CYP4F2 (0.45) PPARAKDM4EMEN1ALDH1A1KMT2A
SCHEMBL506923 0.79 SMN1; SMN2 (0.46) KDM4EALDH1A1CYP4F2CYP4A11
SCHEMBL16050409 0.79 ALOX5 (0.59) PPARAALOX5PTGS2KDM4EMEN1
SCHEMBL26240041 0.78 LIPG (0.51) PPARAALOX5PTGS2MEN1ALDH1A1
SCHEMBL28267934 0.78 LIPG (0.51) PPARAALOX5PTGS2MEN1ALDH1A1
SCHEMBL27261914 0.78 LIPG (0.51) PPARAALOX5PTGS2MEN1ALDH1A1
SCHEMBL16050494 0.78 ALDH1A1 (0.51) PPARAKDM4EALDH1A1BIDMCL1
SCHEMBL19542666 0.78 BID (0.48) PPARAALOX5PTGS2KDM4EALDH1A1
SCHEMBL27349716 0.78 LIPG (0.51) PPARAALOX5PTGS2MEN1ALDH1A1
SCHEMBL2972991 0.78 MEP1B (0.48) KDM4EALDH1A1CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225303-A1 8-Oxoadenine Compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225303-A1 8-Oxoadenine Compound TLR7, CCR8, TLR8 PPARA 2948/4885ALOX5 285/4885PTGS2 1288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.